MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 112 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 1,921,118 | $37,385,000 | 54.94% |
Frazier Life Sciences Management, L.P. | 3,566,912 | $69,412,000 | 6.55% |
NEA Management Company, LLC | 4,187,801 | $81,495,000 | 4.19% |
Highlander Partners, L.P. | 122,980 | $2,393,000 | 3.15% |
Prosight Management, LP | 161,527 | $3,143,000 | 2.48% |
Novo Holdings A/S | 2,027,324 | $37,931,000 | 1.87% |
CADIAN CAPITAL MANAGEMENT, LP | 1,385,997 | $26,972,000 | 1.82% |
MPM BioImpact LLC | 288,531 | $5,615,000 | 1.56% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,244,434 | $63,137,000 | 1.30% |
Rock Springs Capital Management LP | 1,717,733 | $33,427,000 | 0.97% |